STAT

DECEMBER 30, 2024

Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration asked manufacturers in 2013 to voluntarily test the devices on more diverse skin tones, according to a study published Monday in JAMA. The study and a related editorial suggest clearer guidance, enforcement, and possibly legal action may be necessary to ensure the devices work well on all skin tones.

Documentation 303

Documentation 303

Express Pharma

DECEMBER 30, 2024

The pharmaceutical industry is vital to healthcare, fostering innovation for life-saving medications and therapies. However, the journey from research to market application is complex, creating a gap between discoveries and their practical use in patient care. In this context, universities play a crucial role by equipping students with the skills and knowledge needed to translate pharmaceutical research into real-world applications.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

STAT

DECEMBER 30, 2024

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than a decade, the Congressional Budget Office (CBO) ventured to  estimate  the budgetary effects of such a policy for older Americans starting in 2026 for the very first time in a report published in October.  The CBO should be commended for conducting this comprehensive analysis.

277

277

Express Pharma

DECEMBER 30, 2024

On December 29, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 12 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on Complaints and Product Recall. The session provided clarity on the guidelines and cleared the queries of the pharma professionals. Session highlights: Chief Guest: The event began with a keynote address by Anil Matai, Director General, OPPI India.

Documentation 99

Documentation Communication Packaging Pharmaceutical Companies 99

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

DECEMBER 30, 2024

Axsome Therapeutics is moving ahead with plans to submit its Alzheimer’s disease treatment for Food and Drug Administration approval despite mixed results from two new clinical trial readouts.  Axsome, which is based in New York, announced Monday that its drug AXS-05 met the primary endpoint of one trial testing the therapy for agitation caused by Alzheimer’s, but failed to show statistical significance in another.

258

258

Express Pharma

DECEMBER 30, 2024

Lupin announced the acquisition of Huminsulin in India from Eli Lilly and Company to further enhance its diabetes portfolio. Lupin has been marketing the Huminsulin range of products comprising of Insulin Human, including Huminsulin R, Huminsulin NPH, Huminsulin 50/50, and Huminsulin 30/70, through existing distribution and promotion agreements with Lilly, India.

Diabetes 105

Diabetes 105

Express Pharma

DECEMBER 30, 2024

The Central Drugs Standard Control Organisation (CDSCO) flagged select batches of Pantoprazole Gastro-Resistant Tablets I.P. ( PAN-40) Amoxycillin and Potassium Clavulanate Tablets IP (Augmentin 625 Duo) and termed them as spurious. CDSCO has also listed 111 other drugs and formulations as not of standard quality (NSQ). The CDSCO alert names the brands for which spurious samples were found.

Labelling 104

Labelling 104

Drug Patent Watch

DECEMBER 30, 2024

The regulatory environment in Japan for generic drug development is complex and has undergone significant changes in recent years. This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market.

Drug Development 52

Drug Development Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 30, 2024

Daiichi Sankyo has claimed its first approval, in Japan, for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan

66

66

PharmaTech

DECEMBER 30, 2024

The PharmTech Group editors present our most popular interviews from 2024.

64

64

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

DECEMBER 30, 2024

Learn how digital biomarkers are revolutionising respiratory care by providing personalised, real-time data for better monitoring and management of respiratory diseases.

59

59

Pharmaceutical Technology

DECEMBER 30, 2024

MTX-COVAB is under clinical development by Memo Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

52

52

Compounding Pharmacy of America

DECEMBER 30, 2024

Discover how compounded medications provide effective pain relief for dental dry socket. Learn about personalized solutions to speed healing and ease discomfort. The post Dental Dry Socket Compounded Medication for Pain Relief appeared first on Compounding Pharmacy of America.

Compounding 52

Compounding Compounding Pharmacies 52

Commonwealth Pharmacists Association

DECEMBER 30, 2024

As 2024 draws to a close, we are excited to provide you with an update on recent developments in our various programmes, courtesy of our esteemed programmes staff. The last few months have proved a busy and exciting time for all of our workstreams, and we are excited to bring you further updates as we enter the New Year.

52

52

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Compounding Pharmacy of America

DECEMBER 30, 2024

Learn effective strategies for managing allergies, including compounded medications tailored to your symptoms. Find relief with personalized treatments for allergy care The post Allergy Management and Relief appeared first on Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

Commonwealth Pharmacists Association

DECEMBER 30, 2024

As 2024 draws to a close, we are excited to provide you with an update on recent developments in our various programmes, courtesy of our esteemed programmes staff. The last few months have proved a busy and exciting time for all of our workstreams, and we are excited to bring you further updates as we enter the New Year.

52

52

Compounding Pharmacy of America

DECEMBER 30, 2024

Learn how pediatric compounding pharmacies offer customized medications for children, addressing challenges like taste, dosage, and allergies, while improving treatment outcomes. The post Are you looking for a better way to give your child medicine? appeared first on Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding Dosage 52

Commonwealth Pharmacists Association

DECEMBER 30, 2024

Sarah Cavanagh, our AMS Senior Technical Advisor, reflects on her recent visit to Ghana as part of our Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programme.

52

52

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Commerce

DECEMBER 30, 2024

A dive into the top articles in this sector making waves this year.

52

52

PharmaTech

DECEMBER 30, 2024

In this first of a four-part series, the authors provide an introduction to a practical approach for establishing specification equivalence. The regulatory basis and compliance examples from FDA observations and warning letters are included to support the need for an effective process.

52

52

Pharmaceutical Technology

DECEMBER 30, 2024

The US FDA has granted approval for Bristol Myers Squibbs (BMS) Opdivo Qvantig for subcutaneous use to treat various solid tumours.

52

52

PharmExec

DECEMBER 30, 2024

In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), how new radiological techniques are revolutionizing the diagnosis of conditions like endometriosis and the impact it will have on patients.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

DECEMBER 30, 2024

Tevimbra is already approved in the US for the treatment of unresectable or metastatic oesophageal squamous cell carcinoma (ESCC).

52

52

PharmExec

DECEMBER 30, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

European Pharmaceutical Review

DECEMBER 30, 2024

The use of advanced therapies using cells or genes to achieve significant leaps in medical treatment was perceived as a niche sector just a decade ago, but it has now started to garner a greater level of understanding and recognition in the pharmaceutical industry. Numerous groundbreaking advances have shown these therapies hold potential to revolutionise how we treat, and potentially cure, many conditions, including for patients with underlying genetic or cellular causes of disease that have

Medical Schools 52

Medical Schools 52

World Pharma News

DECEMBER 30, 2024

In a new analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of developing head and neck cancers, including cancers of the mouth and throat. Cancers of the head and neck are the seventh most common forms of cancer worldwide, and rates are rising in low- and middle-income countries. Many studies have assessed whether drinking coffee or tea is associated with head and neck cancer, with inconsistent results.

49

49

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmacy Times

DECEMBER 30, 2024

The disparity highlights opportunities for pharmacists to get involved and address health disparities.

Scheduling Appointments 46

Scheduling Appointments 46

Pharmaceutical Technology

DECEMBER 30, 2024

ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

40

40

Proxsys Rx

DECEMBER 30, 2024

Fair Warning: If you ever dismissively ask that question of someone whos led the planning and launch of a 340B hospitals specialty pharmacy, and did it with no outside support, theres a good chance youll get punched. Yes, its that difficult. WHY is it so hard to build a 340B specialty pharmacy? After all, its true that a 340B specialty pharmacy requires the same pharmacy board licensing as a 340B retail pharmacy.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Pharmacy Management 52

Pharmaceutical Technology

DECEMBER 30, 2024

ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Metastatic Colorectal Cancer.

40

40

Pharmacy Times

DECEMBER 30, 2024

Plaintiff argues that "blacklisting certain individuals with opioid prescriptions was unlawful.

29

29